Liver impairment in critical illness and sepsis: the dawn of new biomarkers?
作者信息
Kluge Martin, Tacke Frank
机构信息
Department of Hepatology & Gastroenterology, Charité University Medicine Berlin, Berlin, Germany.
出版信息
Ann Transl Med. 2019 Dec;7(Suppl 8):S258. doi: 10.21037/atm.2019.12.79.
Abstract
摘要
相似文献
1
Liver impairment in critical illness and sepsis: the dawn of new biomarkers?
Ann Transl Med. 2019 Dec;7(Suppl 8):S258. doi: 10.21037/atm.2019.12.79.
2
Cholestatic liver (dys)function during sepsis and other critical illnesses.
Intensive Care Med. 2016 Jan;42(1):16-27. doi: 10.1007/s00134-015-4054-0. Epub 2015 Sep 21.
3
The Role of Adipokines as Circulating Biomarkers in Critical Illness and Sepsis.
Int J Mol Sci. 2019 Sep 28;20(19):4820. doi: 10.3390/ijms20194820.
4
Protein C in critical illness.
Am J Health Syst Pharm. 2009 Jun 15;66(12):1089-96. doi: 10.2146/ajhp080276.
5
Comparison of qSOFA with current emergency department tools for screening of patients with sepsis for critical illness.
Emerg Med J. 2018 Jun;35(6):350-356. doi: 10.1136/emermed-2017-207383. Epub 2018 May 2.
6
Cholestatic Alterations in the Critically Ill: Some New Light on an Old Problem.
Chest. 2018 Mar;153(3):733-743. doi: 10.1016/j.chest.2017.08.018. Epub 2017 Aug 26.
7
Diagnostic and prognostic biomarkers of sepsis in critical care.
J Antimicrob Chemother. 2011 Apr;66 Suppl 2:ii33-40. doi: 10.1093/jac/dkq523.
8
The Role of Liver Function in the Setting of Cirrhosis with Chronic Infection and Critical Illness.
Crit Care Nurs Clin North Am. 2017 Mar;29(1):37-50. doi: 10.1016/j.cnc.2016.09.006. Epub 2016 Dec 14.
9
Biomarkers and Precision Medicine: State of the Art.
Crit Care Clin. 2020 Jan;36(1):155-165. doi: 10.1016/j.ccc.2019.08.012. Epub 2019 Oct 22.
10
Interpreting Laboratory Tests in Infection: Making Sense of Biomarkers in Sepsis and Systemic Inflammatory Response Syndrome for Intensive Care Unit Patients.
Crit Care Nurs Clin North Am. 2017 Mar;29(1):119-130. doi: 10.1016/j.cnc.2016.09.004. Epub 2016 Dec 14.
引用本文的文献
1
Artificial liver support with Cytosorb and continuous veno-venous hemodiafiltration versus advanced organ support (ADVOS) for critically ill patients with hyperbilirubinemia and acute-on-chronic liver failure (ACLF).
BMC Nephrol. 2025 Aug 4;26(1):432. doi: 10.1186/s12882-025-04342-6.
2
Putative biomarkers of hepatic dysfunction in critically ill sepsis patients.
Clin Exp Med. 2025 Jan 3;25(1):28. doi: 10.1007/s10238-024-01545-3.
3
Bioinformatics study of the TNFRSF1A mechanism involved in acute liver injury in sepsis through the mTOR signaling pathway.
Histol Histopathol. 2025 Mar;40(3):401-409. doi: 10.14670/HH-18-789. Epub 2024 Jul 3.
4
Acute liver failure in pregnancy.
Indian J Gastroenterol. 2024 Apr;43(2):325-337. doi: 10.1007/s12664-024-01571-9. Epub 2024 May 1.
5
The Prognostic Value of a Liver Function Test Using Indocyanine Green (ICG) Clearance in Patients with Multiple Organ Dysfunction Syndrome (MODS).
J Clin Med. 2024 Feb 11;13(4):1039. doi: 10.3390/jcm13041039.
6
Hemoadsorption Therapy for Critically Ill Patients with Acute Liver Dysfunction: A Meta-Analysis and Systematic Review.
Biomedicines. 2023 Dec 27;12(1):67. doi: 10.3390/biomedicines12010067.
7
Population Pharmacokinetic Modeling and Dose Optimization of Acetaminophen and its Metabolites Following Intravenous Infusion in Critically ill Adults.
Eur J Drug Metab Pharmacokinet. 2023 Sep;48(5):531-540. doi: 10.1007/s13318-023-00841-9. Epub 2023 Jun 30.
8
ANALGESIC EFFECT OF TRAMADOL IS NOT ALTERED BY POSTOPERATIVE SYSTEMIC INFLAMMATION AFTER MAJOR ABDOMINAL SURGERY.
Acta Clin Croat. 2021 Jun;60(2):268-275. doi: 10.20471/acc.2021.60.02.13.
9
International Normalized Ratio to Albumin Ratio (PTAR): An Objective Risk Stratification Tool in Patients with Sepsis.
Int J Gen Med. 2021 May 12;14:1829-1841. doi: 10.2147/IJGM.S305085. eCollection 2021.
本文引用的文献
1
Biomarker-assisted identification of sepsis-related acute liver impairment: a frequent and deadly condition in critically ill patients.
Clin Chem Lab Med. 2019 Aug 27;57(9):1422-1431. doi: 10.1515/cclm-2018-1350.
2
Hyaluronic Acid Is a Biomarker for Allograft Dysfunction and Predicts 1-Year Graft Loss After Liver Transplantation.
Transplant Proc. 2018 Dec;50(10):3635-3643. doi: 10.1016/j.transproceed.2018.09.018. Epub 2018 Sep 11.
3
Liver Fibrosis Markers Improve Prediction of Outcome in Non-Acetaminophen-Associated Acute Liver Failure.
Hepatol Commun. 2018 Sep 21;2(11):1331-1343. doi: 10.1002/hep4.1233. eCollection 2018 Nov.
4
Index serum hyaluronic acid independently and accurately predicts mortality in patients with liver disease.
Aliment Pharmacol Ther. 2018 Aug;48(4):423-430. doi: 10.1111/apt.14897. Epub 2018 Jul 4.
5
The intensive care unit course and outcome in acute-on-chronic liver failure are comparable to other populations.
J Hepatol. 2018 Oct;69(4):803-809. doi: 10.1016/j.jhep.2018.04.025. Epub 2018 May 4.
6
Liver macrophages in tissue homeostasis and disease.
Nat Rev Immunol. 2017 May;17(5):306-321. doi: 10.1038/nri.2017.11. Epub 2017 Mar 20.
7
Liver - guardian, modifier and target of sepsis.
Nat Rev Gastroenterol Hepatol. 2017 Jan;14(1):55-66. doi: 10.1038/nrgastro.2016.168. Epub 2016 Dec 7.
8
Cholestatic liver (dys)function during sepsis and other critical illnesses.
Intensive Care Med. 2016 Jan;42(1):16-27. doi: 10.1007/s00134-015-4054-0. Epub 2015 Sep 21.
9
Hyaluronic acid as a non-invasive biomarker of liver fibrosis.
Clin Biochem. 2016 Feb;49(3):302-15. doi: 10.1016/j.clinbiochem.2015.07.019. Epub 2015 Jul 17.
10
Outcome of patients with cirrhosis requiring mechanical ventilation in ICU.
J Hepatol. 2014 Mar;60(3):570-8. doi: 10.1016/j.jhep.2013.11.012. Epub 2013 Nov 23.
Zotero 插件